R&D
R&D Progress
PS-001
Small Molecule Drug (Tablet)
Indication
Type 2 Diabetes
Discovery
Preclinical
Phase I
Phase II
Phase III
NDA
● Current Status: Phase I Clinical Trial in Progress / Phase II Planning
PS-002
Small Molecule Drug (Tablet)
Indication
Type 1 Diabetes
Discovery
Preclinical
Phase I
Phase II
Phase III
NDA
● Current Status: Phase II Clinical Trial Planning
PS-003
Small Molecule Drug (Tablet)
Indication
Others
Discovery
Preclinical
Phase I
Phase II
Phase III
NDA
● Current Status: Under Development
News
- [NEWS] New Force in New Drug Stocks! Pharmasaga to List on Emerging Stock Market on the 27th at Reference Price of NT$120
- [NEWS] Pharmasaga's Innovative Drug for Type 1/2 Diabetes Plans Phase II, Creates Buzz Ahead of Emerging Stock Listing
- [NEWS] Pharmasaga Wins 2025 Taipei Biotech Award - Innovative Technology Award
- [NEWS] Pharmasaga Competes for the North America BIO Convention Startup Competition Championship
- [2025] Pharmasaga's Innovative Diabetes Drug PS1 Demonstrates Curative Potential, Initiates Taiwan-US Clinical Trials
- [2025] Taiwan Participates in BIO 2025 North America Biotech Exhibition: Dual Focus on All-Age Healthcare Layout and International Connections
Contact Us
- Pharmasaga
- Phone number : + 886-2-27938665
- E-mail : contact@pharmasaga.com
- Address : 22 F.-1, No. 93, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221416, Taiwan (R.O.C.)